Borut Božič

2.1k total citations
79 papers, 1.5k citations indexed

About

Borut Božič is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Borut Božič has authored 79 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Rheumatology, 30 papers in Radiology, Nuclear Medicine and Imaging and 20 papers in Immunology. Recurrent topics in Borut Božič's work include Systemic Lupus Erythematosus Research (34 papers), Monoclonal and Polyclonal Antibodies Research (30 papers) and Pharmaceutical Practices and Patient Outcomes (12 papers). Borut Božič is often cited by papers focused on Systemic Lupus Erythematosus Research (34 papers), Monoclonal and Polyclonal Antibodies Research (30 papers) and Pharmaceutical Practices and Patient Outcomes (12 papers). Borut Božič collaborates with scholars based in Slovenia, Netherlands and Poland. Borut Božič's co-authors include Blaž Rozman, Tanja Kveder, Saša Čučnik, Ger J.M. Pruijn, Aleš Ambrožič, Snežna Sodin‐Šemrl, Els Oosterink, Joyce J. B. C. van Beers, Judith Stammen‐Vogelzangs and Polona Žigon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the New York Academy of Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Borut Božič

77 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Borut Božič Slovenia 22 867 405 340 310 296 79 1.5k
H A Austin United States 18 1.2k 1.4× 606 1.5× 322 0.9× 121 0.4× 150 0.5× 29 2.0k
Ariella Kelman United States 14 801 0.9× 515 1.3× 171 0.5× 132 0.4× 142 0.5× 16 1.7k
Y K Onno Teng Netherlands 28 1.9k 2.2× 1.4k 3.4× 647 1.9× 125 0.4× 291 1.0× 107 2.9k
Marwan Bukhari United Kingdom 20 873 1.0× 244 0.6× 145 0.4× 116 0.4× 179 0.6× 80 1.5k
Koshika Soma United States 15 1.4k 1.6× 442 1.1× 77 0.2× 225 0.7× 99 0.3× 24 2.0k
Gernot Hudelist Austria 38 256 0.3× 413 1.0× 246 0.7× 345 1.1× 642 2.2× 163 4.3k
Noha Abdel‐Wahab United States 22 194 0.2× 414 1.0× 74 0.2× 304 1.0× 234 0.8× 60 2.3k
Ana P. Lacerda United States 14 451 0.5× 427 1.1× 49 0.1× 448 1.4× 70 0.2× 66 1.4k
Peter Mollee Australia 25 134 0.2× 300 0.7× 153 0.5× 248 0.8× 997 3.4× 180 2.5k
Silvia Dehler Switzerland 19 380 0.4× 170 0.4× 106 0.3× 320 1.0× 102 0.3× 43 1.4k

Countries citing papers authored by Borut Božič

Since Specialization
Citations

This map shows the geographic impact of Borut Božič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Borut Božič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Borut Božič more than expected).

Fields of papers citing papers by Borut Božič

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Borut Božič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Borut Božič. The network helps show where Borut Božič may publish in the future.

Co-authorship network of co-authors of Borut Božič

This figure shows the co-authorship network connecting the top 25 collaborators of Borut Božič. A scholar is included among the top collaborators of Borut Božič based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Borut Božič. Borut Božič is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Banfi, Giuseppe, Borut Božič, Murat Cihan, et al.. (2024). Point-of-care testing, near-patient testing and patient self-testing: warning points. Clinical Chemistry and Laboratory Medicine (CCLM). 62(12). 2388–2392. 6 indexed citations
2.
Horvat, Nejc, Mitja Kos, Aleš Obreza, et al.. (2017). Curriculum Mapping of the Master’s Program in Pharmacy in Slovenia with the PHAR-QA Competency Framework. SHILAP Revista de lepidopterología. 5(2). 24–24. 5 indexed citations
3.
Atkinson, Jeffrey, Kristien De Paépe, Antonio Sánchez–Pozo, et al.. (2016). A Study on How Industrial Pharmacists Rank Competences for Pharmacy Practice: A Case for Industrial Pharmacy Specialization. SHILAP Revista de lepidopterología. 4(1). 13–13. 5 indexed citations
4.
5.
Kveder, Tanja, et al.. (2014). Anti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries. Autoimmunity. 47(7). 438–444. 3 indexed citations
6.
7.
Lakota, Katja, Gerhard Thallinger, Saša Čučnik, et al.. (2010). Could antibodies against Serum Amyloid A function as physiological regulators in humans?. Autoimmunity. 44(2). 149–158. 11 indexed citations
8.
Laat, Bas de, R. H. W. M. Derksen, Guido Reber, et al.. (2010). An international multicentre‐laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti‐beta2‐glycoprotein autoantibodies. Journal of Thrombosis and Haemostasis. 9(1). 149–153. 40 indexed citations
9.
Homšak, Evgenija, Dušanka Mičetić‐Turk, & Borut Božič. (2010). Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value. Wiener klinische Wochenschrift. 122(S2). 19–25. 22 indexed citations
10.
Frank‐Bertoncelj, Mojca, et al.. (2009). β2-glycoprotein I and annexin A5 phospholipid interactions: Artificial and cell membranes. Autoimmunity Reviews. 9(1). 5–10. 22 indexed citations
11.
Božič, Borut, et al.. (2007). Autoimmune Reactions after Electro‐oxidation of IgG from Healthy Persons. Annals of the New York Academy of Sciences. 1109(1). 158–166. 5 indexed citations
12.
Gašperšič, Nataša, et al.. (2006). Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti- 2-glycoprotein I and anti-annexin A5 antibodies. Lara D. Veeken. 46(1). 81–86. 19 indexed citations
13.
Ambrožič, Aleš, et al.. (2005). Budding, vesiculation and permeabilization of phospholipid membranes—evidence for a feasible physiologic role of β2-glycoprotein I and pathogenic actions of anti-β2-glycoprotein I antibodies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1740(1). 38–44. 12 indexed citations
14.
Božič, Borut, Saša Čučnik, Tanja Kveder, & Blaž Rozman. (2005). Avidity of anti-beta-2-glycoprotein I antibodies. Autoimmunity Reviews. 4(5). 303–308. 20 indexed citations
15.
Ambrožič, Aleš, et al.. (2004). Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Research. 6(Suppl 1). 6–6. 1 indexed citations
16.
Logar, D, Blanka Vidan‐Jeras, Aleš Ambrožič, et al.. (2002). The association of HLA-DR/DQ coding and QBP promoter allelic polymorphism with antiphospholipid antibody response in SLE. Arthritis Research. 4(Suppl 1). 23–23. 1 indexed citations
17.
Rozman, Blaž, et al.. (2000). Immunoserological aspects of idiopathic inflammatory muscle disease.. PubMed. 112(15-16). 722–7. 12 indexed citations
18.
Praprotnik, Sonja, et al.. (1999). Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren's syndrome: a prospective study.. Clinical and Experimental Rheumatology. 17(1). 63–8. 52 indexed citations
19.
Božič, Borut, Tanja Kveder, Mojca Stegnar, et al.. (1997). Influence of Degraded Phosphatidylserine on Binding of Antiphospholipid Antibodies. International Archives of Allergy and Immunology. 112(1). 19–26. 27 indexed citations
20.
Pruijn, Ger J.M., Borut Božič, F. Schoute, Luis A. Rokeach, & Walther J. van Venrooij. (1992). Refined definition of the 56K and other autoantigens in the 50–60 kDa region. Molecular Biology Reports. 16(4). 267–276. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H A Austin Breakdown of academic impact, for papers by Ariella Kelman Breakdown of academic impact, for papers by Y K Onno Teng Breakdown of academic impact, for papers by Marwan Bukhari Breakdown of academic impact, for papers by Koshika Soma Breakdown of academic impact, for papers by Gernot Hudelist Breakdown of academic impact, for papers by Noha Abdel‐Wahab Breakdown of academic impact, for papers by Ana P. Lacerda Breakdown of academic impact, for papers by Peter Mollee Breakdown of academic impact, for papers by Silvia Dehler
Rankless by CCL
2026